Cereno Scientific recalls tranche of convertible bonds and pauses financing from EHGOSF
The Board of Directors of Cereno Scientific has decided to recall the latest tranche that the company issued on 4 January 2019, and to pause until further notice the call-down of new convertible bonds in the funding solution the company entered into with the European High Growth Opportunities Securitization Fund. The Board is evaluating various alternate funding solutions to finance continued operations and the planned Phase II study of its drug candidate, CS1.“We have agreed, in consultation with the European High Growth Opportunities Securitization Fund through their adviser, Alpha Blue